Metraipolis › archive › dc_14d3a7fc9505

A retrospective study of the impact of comorbidity, polypharmacy and demographic factors on patient inclusion and healthcare delivery in phase I oncology trials — Europe PMC PMID:40855012

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40855012
DOI
10.1038/s44276-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-10-10T01:13:27.489Z
SHA-256 of the archived text
d3190e08f8cb90b48b5f7cfe8f8aa7411735f479cecbd4164a4e22f515b7773c
Stable URL of this page
https://metraipolis.com/documento/dc_14d3a7fc9505

How to cite

A retrospective study of the impact of comorbidity, polypharmacy and demographic factors on patient inclusion and healthcare delivery in phase I oncology trials — Europe PMC PMID:40855012 — Europe PMC (en), https://europepmc.org/article/MED/40855012 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_14d3a7fc9505 (Metraipolis archive dc_14d3a7fc9505, sha256 d3190e08f8cb90b48b5f7cfe8f8aa7411735f479cecbd4164a4e22f515b7773c)
BibTeX
@misc{dc14d3a7fc9505,
  title = {A retrospective study of the impact of comorbidity, polypharmacy and demographic factors on patient inclusion and healthcare delivery in phase I oncology trials — Europe PMC PMID:40855012},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40855012},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_14d3a7fc9505; sha256 d3190e08f8cb90b48b5f7cfe8f8aa7411735f479cecbd4164a4e22f515b7773c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40855012. Agents can read the archived copy with the MCP tool read_document.